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Abstract
The cyclin-dependent kinase inhibitor p21 (p21WAF1/Cip1) is a multifunctional protein known to promote cell cycle arrest
and survival in response to p53-dependent and p53 independent stimuli. We herein investigated whether and how it might
contribute to the survival of cancer cells that are in low-nutrient conditions during tumour growth, by culturing isogenic
human colorectal cancer cell lines (HCT116) and breast cancer cell lines in a medium deprived in amino acids and serum. We
show that such starvation enhances, independently from p53, the expression of p21 and that of the pro-apoptotic BH3-only
protein Puma. Under these conditions, p21 prevents Puma and its downstream effector Bax from triggering the
mitochondrial apoptotic pathway. This anti-apoptotic effect is exerted from the cytosol but it is unrelated to the ability of
p21 to interfere with the effector caspase 3. The survival function of p21 is, however, overcome by RNA interference
mediated Bcl-xL depletion, or by the pharmacological inhibitor ABT-737. Thus, an insufficient supply in nutrients may not
have an overt effect on cancer cell viability due to p21 induction, but it primes these cells to die, and sensitizes them to the
deleterious effects of Bcl-xL inhibitors regardless of their p53 status.
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Introduction
p21
cip1/Waf1 (herein after named p21) is a member of the Cip/
Kip family inhibitors of cell cycle progression that associates with
the cyclin/CDK complexes and with PCNA, a processivity factor
for replication polymerase, leading to the inhibition of CDK
activities and DNA replication [1]. p21 is a p53 target gene and it
is a relevant mediator of p53 induced cell cycle arrest in response
to DNA damaging agents and/or oncogenic stress [1,2]. Other
studies have shown that p21 has additional functions as a
differentiation inducer [3,4] and as an inhibitor of apoptosis
induced by DNA-damaging agents [5]. Given the importance of
cell death induction in the clinical effects of chemotherapeutic
drugs, this latter activity is likely to be critical, and to impede
treatment efficiency [1,6].
Although p21 may act as an apoptosis inducer in certain
instances, results obtained in many models indicate it has an anti-
apoptotic effect when cells are treated by genotoxic agents [7–10].
Moreover, some studies have reported that p21 promotes cell
survival in response to antimetabolites, antimitotic and differen-
tiating agents, and proteasome inhibitors [1,11,12]. This implies
that p21 might play a role in the survival of cancer cells that goes
beyond conditions of a p53 dependent response to acute genotoxic
stress. By inference, overcoming its cytoprotective effects may
represent a general, and critical, therapeutical issue. Most
relevantly here, p21 was reported to promote, in vitro, the survival
of embryonic fibroblasts grown in the absence of serum and
treated by rapamycin [13]. Since the activity of the mammalian
target of rapamycin (mTOR) is sensitive to serum and nutrient,
this suggests that p21 might contribute to oncogenesis by playing a
role in the adaptive response of cancer cells to the low-nutrient
environment that typically characterizes the central region of solid
tumors. Whether this is effective in human cancer cells, and what
role p53 might play under these conditions, nevertheless needs to
be elucidated.
Another key issue, partly unresolved, is the molecular
mechanisms through which p21 promotes survival under each of
the aforementioned conditions. p21 may indeed protect cells from
apoptosis by diverse mechanisms. Firstly, these mechanisms may
depend on p21 localization. Some data indicate that, under
conditions of genotoxic stress, inhibition of the apoptotic response
by p21 is linked to its ability to inhibit CDK activities in the
nucleus [5,7,8]. In other cases, p21 was found to prevent apoptosis
from the cytosol [4,14,15]. This process can be regulated by the
ability of the survival Akt kinase to directly induce its
phosphorylation and promote its retention the cytosol [16,17].
Secondly, p21 may exert its effects at different levels of the
apoptotic machinery. Apoptosis is a cell death process whose
efficiency relies in great part on the activation of a cascade of
cysteine active proteases, the so-called caspases. p21 was reported
to bind to and to inhibit the effector caspase, caspase 3, and to do
so from the cytosol [18]. However, cell death induced by caffeine
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3, was linked to a decrease of the expression of p21 and,
consistently, was counteracted by overexpressed p21 [10].
Therefore, the antiapoptotic function of p21 may not only involve
its capacity to inhibit the caspase 3 and may act more upstream in
the apoptotic machinery.
The Bcl-2 family of interacting proteins acts as major regulators
of the mitochondrial apoptotic pathway, representing an integrat-
ing node towards which converge numerous death and survival
signals in mammalian cells [19]. Anti-apoptotic Bcl-2 homologues
preserve mitochondrial integrity by opposing the activity of multi-
domain pro-apoptotic Bcl-2 family members Bax and Bak, which
display sequence conservation throughout three Bcl-2 homology
(BH) domains (BH1-3), and that of their upstream effectors, the
BH3-only proteins (e.g. Bim, Puma, Bad…). This occurs
essentially by physical interactions between anti- and pro-
apoptotic members that involve engagement of the BH3 domain
of the latter by a hydrophobic pocket formed at the surface of the
former. This BH3-binding allows anti-apoptotic proteins to
negatively control the activity of pro-apoptotic Bax itself, the
essential actor of mitochondrial permeabilization and of the
apoptotic response of mammalian cells to multiple stimuli [20].
These physical interactions play a key role in maintaining cell
survival. More specifically, mechanistic investigations revealed that
the interactions required to maintain survival are these that the
anti-apoptotic proteins (such as Bcl-xL) engage with ‘‘activator’’
BH3-only proteins (such as Puma or Bim, which can directly
activate Bax) and with multi-domain proteins themselves (such as
Bax) [21,22]. To the best of our knowledge, whether p21 might
impact on some of these interactions to prevent cell death in some
instances remains currently unknown. It should be noted,
however, that induction of Puma upon DNA damage does not
trigger apoptosis unless p21 expression is abolished, indicating that
p21 can interfere with cell death induced downstream of Puma
[7].
In this study, we investigated the role played by p21 in cell death
induced by serum nutrient starvation. We show that starvation
induces p21 independently from p53 and, that this mitigates the
efficiency of a Puma/Bax dependent apoptotic signal also induced
by starvation. We show, moreover that the anti-apoptotic function
exerted by p21 in starved cells occurs upstream of mitochondrial
permeabilization, at the level of Puma interactions with Bcl-xL.I t
is thus overcome by silencing of Bcl-xL or by the inhibition of its
BH3-binding activity using the ABT-737 compound, even in cells
that carry a p53 mutation. Thus, starved cells might not die due to
p21 induction, but they might be primed to die and sensitized to
Bcl-xL inhibitors such as ABT-737 regardless of their p53 status.
Results
p21 prevents efficient induction of cell death by serum/
nutrient deprivation in HCT116 cells independently from
p53
We studied the potential role of p21 and of p53 in the response
to serum-nutrient starvation using the wild type human colorectal
cancer cells (HCT116 wt) and its isogenic counterparts deficient
for either p21 (HCT116 p212/2) or p53 (HCT116 p532/2).
For this purpose, HCT116 wt, HCT116 p532/2 and HCT116
p212/2 were cultured in minimal EBSS medium and cell death
was measured. HCT116 cells deficient for p21 present a significant
higher sensitivity to induction of cell death by starvation compared
to the isogenic cells wt and p532/2 (Fig. 1A). p21 deficient cells
undergo cell death after 16 h of starvation while 48 h of starvation
are required to promote cell death in wild-type and p53 deficient
cells. Colony formation assays were also performed to evaluate the
long term response of the different cell lines to a period of serum-
nutrient starvation. For that purpose, cells were cultured in
complete medium or placed under starvation condition during
24 h and then seeded at a low density for 2 weeks in complete
medium before visualization of viable clones (Fig. 1B). Whereas
approximately half of wild-type HCT116 cells and p53 deficient
cells formed colonies under these conditions, only one tenth of p21
deficient cells still formed colonies after the same treatment. Thus,
p21 significantly delays cell death induced by serum-nutrient
starvation.
As it was recently described that the hypersensitivity to
apoptotic stimuli of HCT116 p212/2 cells could be due to
enhanced p53 stability, and not to inactivation of p21 sensu stricto
[23], we analyzed whether the enhanced sensitivity of HCT116
p212/2 cells to starvation induced cell death was a direct
consequence of p21 absence. We thus directly down regulated its
expression, using RNA interference, in HCT116 wt cells. Silencing
of p21 was sufficient to sensitize HCTT116 wt cells to starvation
induced cell death (Fig. 1C). In contrast, silencing of p53 had no
effect on the viability of starved HCT116 wt cells and did not
protect HCT116 p212/2 cells from starvation-induced death
(Fig. 1 C–D, and Fig. S1A). Thus, p53 is dispensable for p21
sensitive induction of apoptosis by starvation. Knock down of p21
was efficient to sensitize to starvation induced cell death in
HCT116 p532/2 cells (Fig. 1E and Fig. S1B). Of note, p53
expression was not affected by knock down of p21 by RNA
interference in HCT116 wt cells, suggesting that cell death
induced in p21 depleted cells is unlikely to result from increased
p53 levels (Fig. 1C).
Taken together, these data indicate that the higher sensitivity of
the HCT116 p212/2 cells to starvation is genuinely due to their
lack of p21 expression, and that stabilisation of p53 is unlikely to
play a role.
Serum-nutrient starvation induced an apoptosis
response mediated by Bax and Puma in p212/2
deficient cells
To test if the mitochondrial apoptotic pathway could account
for starvation induced cell death in HCT116 p212/2,w e
measured apoptosis levels in wild-type, p212/2 and p532/2
HCT116 cells placed 24 h in starved medium (EBSS) or in
complete medium (CM) as a control. Apoptosis was assayed by
quantification of the expression of the APO2.7 marker by flow
cytometry. Under the conditions used, significant rates of
apoptosis were only detected in starved HCT116 p21 2/2 cells
whereas signals detected in starved wt and p532/2 cells were
very low and comparable to these measured in cells grown under
control conditions (Fig. 2A). Consistent with the notion that
starvation triggered apoptosis in p21 deficient cells, we found, after
subcellular fractionation, that starved HCT116 p212/2 exhib-
ited released cytochrome C in starved condition (Fig. 2B).
Since pro-apoptotic Bcl-2 family members act as major actors of
mitochondrial permeabilization, we analyzed whether such
proteins contribute to p21-sensitive cell death signals induced by
starvation. In order to investigate a role for Bax in starvation-
induced apoptosis, we investigated the response of HCT116
p212/2 Bax2/2 to starvation (Fig. 2C) and we found that cell
death was not induced by serum-nutrient starvation in such cells.
These data are in agreement with previous data which showed
that serum-starvation induced mainly apoptotic features upon
starvation of Bax expressing HCT116 cells and not in Bax
deficient HCT116 cells [24].
p21 Inhibits Starvation Induced Cell Death
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only protein Puma plays a key role as an upstream activator of Bax
[21], we also analysed the response to starvation of double
deficient p21-Puma- cells. These cells remained essentially viable
upon starvation, while cells only deficient for p21 presented a high
mortality under the same conditions. This result indicates that, in
the absence of p21, starvation induced cell death is mediated by
Bax and Puma (Fig. 2C).
Analysis of the expression of several Bcl-2 members in parental
cells or in cells deficient for p21 showed that the expression of two
BH3-only proteins, Puma and Bim, was increased under starvation,
regardless of the p21 status. In particular, a 2–3 fold increase in
Puma levels was induced by starvation, both in wt and p212/2
cells (P value.0,05, Fig. 2D right panel). Bcl-xL, Bcl-2, Mcl-1 and
Baxlevels remained essentiallyunchanged bystarvation,whether or
not p21 was expressed in HCT116 cells (Fig. 2D).
Figure 1. Role of p21 and p53 in cell death induced by serum nutrient starvation. (A) The indicated cells were placed in complete medium
(CM) or in starved medium for 16 h, 24 h or 48 h (EBSS) and cell death was assayed by a trypan blue-staining. Data presented are mean 6 SEM of
three independent experiments. (B) The indicated cells were placed in complete medium (CM) or in starved medium during 24 h and then seeded at
a low density for 2 weeks in complete medium before visualization of viable clones by crystal violet staining. (C, D and E) The indicated HCT116 cells
were transfected with the indicated siRNA. 48 h later, cells were starved in EBSS medium for 24 h (EBSS) or not (CM). Western blot analysis was
performed to confirm silencing and cell death was assayed by a trypan blue-staining. Data presented are mean 6 SEM of three independent
experiments.
doi:10.1371/journal.pone.0023577.g001
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investigate whether this protein was involved, as Puma, in
starvation induced cell death. To measure the contribution of
Bim, and to confirm that of Bax and Puma in starvation-induced
apoptosis in HCT116 p212/2, their expression was silenced by
RNA interference. Efficiency of the siRNAs used was confirmed
by western blot (Fig. 2E). HCT116 p212/2 cells proved slightly
sensitive to transfection with control siRNA itself (note the slight
increase in cell death in Figure 1D compared to Figure 1A). We
could nevertheless observe that the Puma siRNA did protect
HCT116 p212/2 from cell death induced by starvation similarly
to the Bax siRNA (Fig. 2E), consistent with results obtained with
the HCT116 p212/2 Bax2/2 and HCT116 p212/2
Puma2/2 cell lines (Fig. 2C). In contrast, down regulation of
Bim had no effect on cell viability of starved p212/2 cells
(Fig. 2E).
These data indicate that Bax and Puma, but not Bim, are key
players of apoptosis induced by starvation in p21 deficient cells.
p21 survival function does not involve interactions with
caspase 3
It was described that p21 could exert an anti-apoptotic function
through its ability to physically interact with, and to inhibit,
caspase 3 [18]. We thus reasoned that, if the cytoprotection
exerted by p21 in starved cells relied solely on this interaction, then
p21 might not protect cells that lack caspase 3 against starvation
induced apoptosis. The breast cancer MCF7 cell line was used
because these cells do not express caspase 3 due to a deletion
mutation in exon 3 of their caspase-3 gene [25]. 24 hours of serum
nutrient deprivation induced low rates of cell death in the MCF7
cells (Fig. 3A). p21 protein expression levels were indeed strongly
increased under serum-nutrient starvation conditions in MCF7
cells while the expression of p53 remained stable (Fig. 3B). To
determine if p21 was involved in the survival of starved MCF7
cells, RNA interference was used as before to efficiently silence p21
expression (Fig. 3C). As observed above in HCT116 cells, knock
down of p21 did not detectably modify the expression of p53 in
Figure 2. Puma and Bax as key actors of apoptosis induced by starvation in p21-negative HCT116 cells. (A) The indicated cells were
placed in complete medium (CM) or in starved medium for 24 h (EBSS). Apoptosis was assayed by APO 2.7 staining using flow cytometry. Data are
expressed as a percentage of the total population. (B) Mitochondria (M) and S100 (S100) lysates from HCT116 p212/2 cells, starved 16 h in EBSS
medium (EBSS) or not (CM), were analysed by western blot analysis for F1ATPase and Cytochrome C (Cyt C). (C) Viability of the indicated cells placed
under starvation during 24 h was analyzed by PI staining followed by flow cytometry. (D) The indicated cells were placed under complete medium
(CM) or in starved medium (EBSS). After 24 h, protein extracts were prepared and the expression of the indicated protein was analysed by western
blotting. The amount of Puma was evaluated in each condition by densitometric analysis from three independent experiments and normalized to the
amount of Puma level measured in complete medium in wild-type cells (E) The p21 negative HCT116 cells were transfected with the indicated siRNA.
48 h later, cells were starved in EBSS medium for 24 h. Western blot analysis of Bax, Puma and Bim was performed and cell death was assayed by a
trypan blue-staining. Data presented in (A), (C) and (E) are mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0023577.g002
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p21 expression sensitized MCF7 cells to induction of cell death by
serum-nutrient starvation (Fig. 3C).
These data indicate that the induction of p21 by starvation, and
the cytoprotection exerted by p21 extend to another cell line. They
imply, moreover, that the anti-apoptotic activity of p21 under
these conditions does not only rely on its interaction with caspase
3.
p21 expression is enhanced by starvation independently
from p53
Under DNA damage, the protective effect of p21 is due to its
transcriptional activation by p53 [1]. We thus investigated whether
p21 expression was increased in response to starvation in HCT116
cells and whether p53 impacted on this process. The p21 protein
expression level was strongly enhanced in wild-type HCT116 cells
placed under serum-nutrient starvation conditions, even though
this induction was rather weaker than that induced by etoposide, a
genotoxic drug (Fig. 4A). Starvation induced increase of p21
protein level was also observed in p53 deficient HCT116 cells
while, as expected, induction of p21 by etoposide in these cells was
strongly affected (Fig. 4A). Consistently, p21 was still found
induced in starved HCT116 wild-type cells in which p53 was
silenced by RNA interference (Fig. 1C). To analyze whether
enhancement of p21 expression occurred at a transcriptional level,
RNAs were extracted from wild-type and p53 deficient cells
cultured in control conditions (complete medium), placed under
starvation or treated with 50 mM etoposide for 6 hours and Q-
PCR analysis of p21 mRNA expression was performed (Fig. 4B).
As expected, p21 mRNA was enhanced by etoposide in wild-type
cells but not in p53 deficient cells. In contrast starvation had no
major impact on p21 mRNA levels in either cell line, indicating
that p21 induction by starvation may not occur at the level of
transcription.
These results indicate that the induction of p21 in starved cells
relies on a mechanism distinct from that involved in its induction
upon DNA damage, in that it is neither p53 nor, more generally,
transcription dependent.
Cytoplasmic p21 exerts cytoprotection in starved cells
The cellular functions of p21 depend upon the cytoplasmic or
nuclear localization of the protein [4]. We thus analyzed the
intracellular localization of p21 upon starvation by subcellular
fractionation. As expected, a high level of p21 was found in the
nuclear fraction of cells treated during 24 h with etoposide
(Fig. 5A). In contrast, under starvation, p21 was found
preferentially in the cytoplasmic fraction. This profile of expression
was comparable to that observed in non-starved cells and it stayed
essentially unchanged during the course of starvation (Fig. 5A).
Analysis of the localisation of p53 indicated that it was mostly
localized in the nucleus fraction in cells cultured in complete
medium, under starvation or treated with etoposide (Fig. 5A).
To confirm these results, the localisation of p21 was determined
by immunohistochemistry 24 h after starvation or genotoxic
treatment in HCT116 and MCF7 cells (Fig. 5B and data not
shown). Again, p21 was detected essentially in the cytoplasm of
starved HCT116 cells and in that of HCT116 cells placed under
control conditions (Fig. 5B). Quantitative analysis indicated that in
either condition, p21 was present respectively in the nucleus of a
limited, and comparable percentage of cells. In contrast, it was
found preferentially localized in the nucleus of HCT116 cells
treated with a genotoxic agent (Fig. 5C). Similarly, p21 localized in
the cytosol of control and starved breast cancer MCF7 cells, while
it preferentially localized in the nucleus of MCF7 treated with
etoposide (Fig. 5C).
The cytosolic localization of p21 in starved cells suggests that
p21 does not need to localize in the nucleus to exert its
cytoprotective activity. To substantiate this, we deleted the nuclear
localisation sequence of p21 located in the C-terminal region,
leading to a truncated variant (DNLSp21), transduced it (or full
length p21) in HCT116 p212/2 cells and induced starvation.
Transfection of p21 deficient HCT116 cells with vectors
containing the full-length p21 cDNA or the DNLSp21 mutant
lead to expression of the corresponding p21 variant as confirmed
by western blot (Fig. 5D). Analysis of the localisation of ectopic p21
by immunocytochemistry showed that full-length p21 protein was
detected in both nucleus and cytoplasm while the truncated
DNLSp21 protein remained in the cytoplasm as expected (data not
shown). To discriminate successfully transfected cells from
untransfected cells, we used a vector that allowed the expression
of bicistronic mRNAs in which the gene encoding the green
fluorescent protein (GFP) used as a marker was translated from the
same mRNA as p21 (full length or lacking its NLS) due to the
presence of an IRES sequence. This system allowed us to
investigate, by time-lapse videomicroscopy, the ability of the
different constructs to rescue HCT116 p212/2 cells from cell
death induced by starvation, through quantification of the
percentage of GFP positive cells that exhibited morphological
features of cell death as a function of time under conditions of
starvation (Fig. 5E). HCT116 p212/2 cells that expressed full-
Figure 3. Survival function of p21 in the Caspase 3 deficient MCF7 cells. (A) The indicated cells were starved in EBSS medium for 24 h (EBSS)
and cell death was assayed by a trypan blue-staining. (B) MCF7 cells were placed in complete medium (CM) or starved in EBSS medium (EBSS) for
24 h. Western blot analysis was performed to analyse p21 and p53 expression. (C) MCF7 cells were transfected with the indicated siRNA. 48 h later,
cells were starved in EBSS medium for 24 h (EBSS) or not (CM). Western blot analysis of p21 and p53 was performed and cell death was assayed by a
trypan blue-staining. Data presented in (A) and (C) are mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0023577.g003
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sensitive to starvation that the HCT116 p212 cells transfected
with the empty vector.
Thus, the anti-apoptotic function of p21 under starvation does
not require its nuclear localisation.
The protective function of p21 is overcome by inhibition
of Bcl-xL in starved cells
The data described above imply that p21 prevents cell death in
starved cells at a level that occurs upstream of mitochondrial
permeabilization, but downstream of Puma induction. Since anti-
apoptotic Bcl-2 family members function in part by preventing
Puma to directly activate Bax [19], we investigated whether
inhibition of some of these proteins, by ABT-737, a potent
inhibitor of the BH3 binding activities of Bcl-2 and Bcl-xL [26],
might overcome the protective function of p21. We tested the
ability of ABT 737 to sensitize wild-type, p53 or Bax deficient
HCT116 cells to serum nutrient starvation. Treatment of wild-
type and p53 deficient HCT116 cell lines with 1 mM of ABT-737
significantly enhanced their cell death response to 24 h of
starvation while viability of Bax deficient cells was not affected
(Fig. 6A). MCF7 cells were also sensitised to ABT-737 when
combined to serum nutrient starvation condition (Fig. 6A).
Notably, and in contrast, ABT-737 barely affected the already
high cell death rates induced by starvation in HCT116 p212/2
cells (Fig. 6A).
To confirm that at least one target of ABT-737 was involved in
the effects reported above, we investigated whether depletion of
Bcl-xL phenocopied the effects of ABT-737 in starved cells. Bcl-xL
was silenced by RNA interference in HCT116 wild-type cells and
the efficiency of the siRNAs used was checked by western blot
(Fig. 6B). Knockdown of Bcl-xL expression by RNA interference
proved sufficient to sensitize wild-type HCT116 to starvation
(Fig. 6B). Taken together, these data indicate that the BH3-
binding activity of Bcl-xL contributes to p21-mediated survival in
starved cells.
We inferred from the assays above that p21 might impact on
some of the interactions Bcl-xL engages with its proapoptotic
counterparts, and that changes in these interactions might account
for the differential sensitivity of the wild type and p212/2
HCT116 cells in response to starvation. To test this hypothesis the
intermolecular interactions between endogenous Bcl-xL, Puma
and Bax were analysed by coimmunoprecipitation experiments in
wild type and p21 deficient HCT116 cells placed in complete
medium or under starvation. The amount of Puma bound to Bcl-
xL was increased upon starvation of wild-type cells but this did not
seem to be the case in p212/2 cells (Fig. 6C). We quantified,
from three independent experiments, Puma levels that coimmu-
noprecipitated with Bcl-xL in wt or p212/2 cells that were
starved or grown in control conditions. This confirmed that Puma
bound to Bcl-xL was significantly increased by starvation in cells
expressing p21, and that this was not the case in p212/2 cells
(Fig. 6D). Since Puma expression is induced by starvation
regardless of p21 status, and since Bcl-xL levels are similar in all
conditions (Fig. 2D), this observation suggests that, in starved p21
expressing cells, the quantity of Puma molecules free of Bcl-xL is
lower than that in starved p21 deficient cells. Of note, the
interaction between Bcl-xL and Bax appeared not to be modified
under starvation in either cell line (Fig. 6C).
These data indicate that starvation affects Bcl-xL interactions
with Puma differentially in wild-type and p21 deficient cells.
Consistently, the anti-apoptotic function exerted by p21 in starved
cells can be overcome by silencing of Bcl-xL or by the inhibition of
its BH3-binding activity, even in cells that lack p53 expression.
Discussion
Under conditions that activate p53, the induction of p21 by p53
was shown to highly contribute to counteract apoptotic signals also
induced downstream of p53 [1,4,5]. The work described here
establishes that under conditions of nutrient deprivation, p21
protects cells from induction of apoptosis in a completely different
setting. p21 may thus not only be an actor of the response of tumor
cells to chemotherapy, but also contribute to their aberrant
survival during tumor growth, even in the absence of treatment.
Recently, a possible caveat in the use of HCT116 p212/2 cells
was reported, as their high sensitivity to two non genotoxic drugs,
imatinib and gefitinib, was incriminated to the coincidentally high
levels of p53 present in these cells rather than to p21 deficiency
[23]. We show here that the direct silencing of p21 expression in
wild type HCT116 and in another cell line suffices to sensitize
these cells to starvation induced cell death, and its ectopic
expression in HCT116 p212/2 cells promotes resistance against
starvation induced cell death. These data clearly demonstrate that
p21 protects cells against starvation-induced apoptosis.
Figure 4. Serum-nutrient starvation enhancement of p21 protein levels. (A) The indicated cells were placed in complete medium (CM),
treated 24 h with 50 mM of etoposide (Eto) or starved 24 h in EBSS medium (EBSS). Western analysis was performed to detect p21. (B) The indicated
cells were placed in complete medium (CM), treated with 50 mM of etoposide (Eto) or starved in EBSS medium (EBSS) during 6 h for qPCR analysis.
p21 mRNA level is expressed as relative values with two house-keeping genes and normalized to complete medium condition.
doi:10.1371/journal.pone.0023577.g004
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p21 is that it does not appear to counteract a p53 dependent death
signal, and that it is thus susceptible to be functional even in tumor
cells that carry p53 mutations. Indeed, the silencing of p21
similarly sensitized wild-type or p532/2 HCT116 cells to
starvation. Moreover, the silencing of p53 did not modify the
response of the HCT116 p212/2 cells to starvation.
Another feature that distinguishes the role played by p21 in
starved cells from that it plays in DNA damaged cells is that p21
induction by starvation appears to be neither p53 dependent (as
judged by the increase in p21 protein levels in starved p53
deficient cells) nor transcriptional (as judged by the lack of overt
effect of starvation on p21 mRNA levels). Our observations recall
that p21 was reported induced by serum released, independently
of p53, not only at a transcriptional but also at a post-
transcriptional level [27]. We did observe that serum withdrawal
induced p21 but at a lower level than that induced by depletion of
both serum and amino acids, indicating that the combined
starvation is required for a full induction of p21 (Fig. S2). We
speculate that p21 induction in response to serum-nutrient
starvation may result from a stabilisation of the protein due to
posttranslational modifications that most likely occur in the
cytoplasm [16][28]. Consistently, our data indicate that the anti
apoptotic function of p21 in starved cells is associated with its
Figure 5. Impact of intracellular localization on the survival function of p21. (A) Nuclear versus cytoplasmic extracts prepared at the
indicated times from HCT116 wt cells place under EBSS or not (CM), or treated with 50 mM of etoposide (Eto) for 24 h. Western analysis was
performed for p21, p53 and F1ATPase and PARP. (B) Immunostaining of p21 in HCT116 wt cells placed under complete medium (CM), starved
medium (EBSS) or treated with 50 mM of etoposide (Eto) for 24 h. Nucleus was stained with DAPI. (C) Quantification of immunostaining of p21 in
HCT116 and MCF7 cells. The amount of cells containing a nuclear p21 localisation was expressed as a percentage of total cells detected with DAPI
staining. (D) Western blot analysis of ectopic p21 in HCT116 p212/2 transfected with either pGFPires21FL expressing the full-length p21 protein (FL)
or with pGFPires21DNSL (DNSL) expressing the p21 protein deleted from its C-terminal NSL domain. (E) HCT116 p212/2transfected cells with the
indicated vector were placed in EBSS medium and followed by time-lapse videomicroscopy. The vectors used allowed the expression of the GFP
concomitant with p21, due to the presence of an IRES element. The percentage of transfected (ie GFP-expressing) cells exhibiting morphological
features of cell death was assayed during 24 h. Data presented in (C) and (E) are mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0023577.g005
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was observed in HCT116 and MCF7 cells placed under starvation
and p21 remained mostly in the cytosol while as expected,
etoposide almost induced a complete nuclear localisation of p21.
Since the ectopic expression of a p21 protein deleted from its NSL
domain was as capable as the full-length p21 protein to protect
p212/2 HCT116 cells from apoptosis, the nuclear localisation of
p21 appeared not required to counteract starvation-induced
apoptosis. Several studies strongly suggest that p21 may have
death-inhibitory functions in the cytoplasm independently of its
ability to induce cell cycle arrest via inhibition of caspase 3 or
kinase activities [14,15,17,18]. However, our data indicate that the
survival function of p21 in response to starvation may not solely
deal with its ability to inhibit the pro-caspase 3, as silencing of p21
promoted cell death in starved MCF7 cells that do not express
caspase 3. In agreement with this, when transfected with an
antisense p21 oligodeoxynucleotide MCF7 cells undergo apoptosis
associated to the attenuation of p21 levels [29].
Our data argue that, in starved cells, p21 counteracts a
mitochondrial apoptotic pathway that relies on Bax and on its
upstream effector Puma to be efficient. Triggering of this pathway
by starvation most likely relies on the induction of Puma
expression under these conditions. Q-PCR data indicate that
starvation induces Puma mRNA levels and that it does so even in
p53 deficient cells (data not shown). Consistently, the increased of
Puma protein level was also observed in p53 2/2 cells (Fig. S3)
indicating that the mechanism responsible for Puma induction
might be p53 independent. Thus, the difference of p53 level
between wt and p212/2 cells may not interfere with Puma
induction by starvation. Consistently, serum-nutrient depletion
was found to increase Puma at a similar level in wt and p212/2
cells, indicating that p21 does not impact on Puma induction, and
that p21 prevents cell death despite Puma induction. Under serum
starvation, Puma was also described increased in various cancer
lines that are mutant or null for p53, and it was reported to play a
major role in the apoptotic response under these conditions [30].
Figure 6. Sensitization to starvation induced cell death by down regulation or inhibition of Bcl-xL. (A) Inhibition of the BH3 domain of
Bcl-2/Bcl-xL sensitizes starved cells independently of p53. The indicated cells were placed in complete medium (CM) or starved in EBSS medium for
24 h (EBSS) and treated with 1 mM of ABT-737 or not and cell death determined by blue trypan assay (**, ***, significantly different from cells placed
in complete medium). (B) HTC116 cells were transfected with the indicated siRNA. 48 h later, cells were starved in EBSS medium for 24 h (EBSS) or not
(CM). Western analysis of Bcl-xL was performed and cell death assayed by a trypan blue-staining. (C) Wild-type and p212/2 HCT116 cells were placed
in complete medium (CM) or starved in EBSS medium for 24 h (EBSS). Expression of Bcl-xL and Puma and Bax in cell lysates was analysed by western
blot. Cells lysates were immunoprecipated (IP) with an anti-Bcl-xL antibody or an anti-Flag antibody as a control, and the presence of Bcl-xL and Puma
and Bax in the immunoprecipitated fractions was analysed by immunoblotting. The amount of Puma that co-immunoprecipitated with Bcl-xL
(evaluated by densitometric analysis and normalized to the amount of immunoprecipitated Bcl-xL) in EBSS condition divided by the amount of Puma
that co-immunoprecipitated with Bcl-xL (evaluated by densitometric analysis and normalized to the amount of immunoprecipitated Bcl-xL)i n
complete medium condition are shown in wilt type and p21 deficient cells as indicated. Data presented in A, B and C are mean 6 SEM of three
independent experiments.
doi:10.1371/journal.pone.0023577.g006
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this transcriptional activation of PUMA [30].
Our data suggest that Puma might form under starvation
different complexes with Bcl-xL in wild-type and p21 deficient
HCT116 cells and we believe that this accounts, at least in part,
for the difference of sensitivity between these cells. Thus, a
complete mechanistic understanding of the cytoprotective effect of
p21 requires to understand how it regulates Puma Bcl-xL
interactions. Since p21 does not appear to impact on the
expression of other Bcl-2 family members such as Mcl-1 that
might indirectly impact on these interactions, we speculate that
post-transcriptional modifications of either partner may be
involved. Phosphorylation of Bcl-xL at the ser62 residue was
reported to influence its interaction with Bax in certain conditions
[31]. Yet, we were not able to detect under starvation Bcl-xL
phosphorylated at the ser62 in the HCT116 cell lines (data not
shown). The phosphorylation status of Bax, Puma, Bcl-xL and p21,
their implications in starvation-induced apoptosis and the kinase(s)
potentially involved need to be further characterized. One
interesting candidate pathway is the one that relies on the c-Jun
N-terminal Kinase (JNK). This kinase is activated by environ-
mental stresses including serum nutrient starvation, and it was
described to play a role in the regulation of the function of some
Bcl-2 proteins [32,33]. JNK1 also plays a role in the transcrip-
tional regulation of Puma [34]. Moreover, JNK1 phosphorylates
p21 leading to the inhibition of its ubiquitination and its
stabilisation in p53 null K562 cells under oxidative stresses [35].
Conversely, p21 might mitigate this pathway by interfering with
ASK1 [15].
Regardless of the exact mechanism involved in the cytoprotec-
tive effect exerted by p21 in starved cells, our data imply that they
converge towards anti-apoptotic Bcl-2 proteins, and that the
inhibition of these proteins should overcome this effect. Consistent
with this, silencing of Bcl-xL was sufficient to sensitize HCT116
cells to starvation. Similar results were obtained using ABT-737,
which indicates that the inhibitory effect of Bcl-xL involves its BH3
binding activity. Strikingly, serum-nutrient withdrawal combined
with the ABT 737 compound induced cell death in wild-type or
p532/2 HCT116 cell lines and in breast cancer cell lines
containing a wild-type p53 or mutant p53 protein (such as the p53
mutant (R280K) MDA-MB 231 and (R249S) BT549 cells (data
not shown).
Thus, p21 expressing, starved cells are primed to die
independently of their p53 status resulting in a high sensitivity to
ABT-737. Notably, p21 protein is overexpressed in various human
cancers and this upregulation correlates positively with aggressive
tumours (for list of references see Table 1 in Abbas T et al, 2009)
[28]. More specifically, cytoplasmic expression of p21, which is
common in human malignancies, was shown to be of bad
prognosis in breast cancer [36,37]. Our data imply that this may
result from contextual cues, and reflect the existence of cells that
resist to the deleterious effects of starvation. They imply, moreover
that the use of compounds such as ABT-737 may overcome the
survival, and promote the destruction, of tumor cells that express
cytoplasmic p21.
Materials and Methods
Cell lines and cell culture
Human colorectal cell lines derived from HCT116 (p212/2,
p532/2, p212/2Puma2/2 and p212/2Bax2/2) were
kindly provided by Dr B. Vogelstein (The John Hopkins Kimmel
Cancer Center, Baltimore, MD). The MCF7 (ATCC-HTB-22)
cell line was obtained from ATCC. All cell lines were incubated at
37uC and humidified 5% CO2-95% air in growth media are
supplemented with 2 mM L-glutamine, 100 U/mL penicillin,
100 mg/mL streptomycin and 10% fetal calf serum (FCS), unless
otherwise stated. HCT116 cells were grown in McCoy’s 5A and
MCF7 in RPM1-1640 supplemented with 0,023 units/ml bovine
insulin. To induce serum nutrient starvation, cells were washed
twice in PBS and incubated in Earle’s Balanced Salt Solution
(EBSS) supplemented with 0.1% BSA and 0.1 g/L MgCl2. When
specified, etoposide were used at 50 mM. ABT-737 was synthe-
sized as previously described and used at 1 mM (24).
Plasmids, siRNAs and transfection
The full–length p21 gene and the p21 gene deleted from its NLS
domain (24 amino acids at the C-terminal end) were cloned into
the pGFPires vector (Clontech) after amplification by PCR using
the sense primer: 59- ATGTCAGAACCGGCTGGGGAT-39 and
the antisense primer 59-TTAGGGCTTCCTCTTGGAGAAG -
39 or 59- TTATCGACCCTGAGACTGCCT-39. The plasmids,
named pGFPires21FL and pGFPires21DNSL respectively, were
sequenced. pGFPires, pGFPires21FL and pGFPires21DNSL were
transfected using Lipofectamine 2000 (Invitrogen) into HCT116
p212/2 cells and the expression of the ectopic p21 proteins was
checked by western blot analysis. The siRNAs were purchased for
siScramble (SC37007), sip21 (SC29427) from Santa Cruz, sip53
(AMS1331) from Applied Biosystem, siBax (60730232) from IDT
DNA, siPuma (4380) and siBcl-xL (3458) from Dharmacon and
siBim (6461) from Cell Signaling. Cells were transfected using the
Hiperfect transfection reagent (QIAGEN) according to manufac-
turer’s instructions and were incubated with nucleotides for 48 h
before subsequent experiments.
RNA extraction and quantitative real-time PCR
Total RNAs were extracted with RNAeasy mini kit (Qiagen).
The quality of the RNAs was assessed by analysis the 28S:18S
rRNA ratio using the RNA 6000 Nano Assay kit and the Agilent
2100 bioanalyser (Agilent Biotechnologies). One microgram of
RNA was retro-transcribed using Supers cript transcriptase
(Superscript II, Invitrogen). Following foward and reverse primers
designed with Amplifix software were used: p21 (59-CAGCAT-
GACAGATTTCTACCAC -39 and 59-GAGACTAAGGCA-
GAAGATGTAGAG -39), rplpO (59-GATGACCAGCCCAAAG-
GAGA -39 and 59- GTGATGTGCAGCTGATCAAGACT-39),
ß2microglobulin (59-GGCATCTTCAAACCTCCATGATG -39
and 59- TTCACCCCCACTGAAAAAGATGA -39). Real time
PCR was carried out using the Brilliant Sybr Green QPCR core
reagent kit (Stratagene) and the thermocycler of the MX-4000
multiplex Quantitative PCR system (Stratagene). Quantitative
normalization of cDNA in each sample was performed using rplpo
and b2-microglobulin mRNAs as internal control. Relative
quantification was carried out using the DDCt method.
Immunoblot analysis and antibodies
Total proteins were extracted in 1% NP-40, 0.5% sodium-
deoxycholate, 0.1% SDS supplemented with protease inhibitor
MiniH from Roche. Nuclear extracts were obtained by subcellular
fractionation using the subcellular protein fractionation kit
(Thermo Scientific Pierce) according to the manufacturer’s
instructions. Mitochondria and S100 fractions were obtained by
subcellular fractionation. The cells were scraped using a Teflon
scraper and centrifuged at 1,000 g for 5 min at 4uC. The cell
pellets were washed twice with ice-cold phosphate-buffered saline
(PBS) and resuspended in volume-per-volume cell extraction
buffer (CEB) (250 mM sucrose, 50 mM HEPES [pH 7.4], 50 mM
KCl, 2 mM MgCl2, 1 mM dithiothreitol, 10 M cytochalasin B,
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to swell for 30 min on ice prior to their homogenization with 50
strokes in an ice-cold 2-ml glass Dounce homogenizer. Unbroken
cells and nuclei were pelleted by centrifugation at 750 g for 10 min
at 4uC. Mitochondria were collected from the resulting superna-
tants by centrifugation at 13,000 g for 15 min at 4uC. Mitochon-
drial pellets were resuspended in volume-per-volume in CEB
buffer. The S100 fraction was obtained by ultracentrifugation of
the resulting supernatants at 100,000 g for 30 min at 4uC. The
integrity of the nuclear, mitochondria and S100 extracts was
checked by the analysis of the expression by immunoblot of the
nuclear PARP protein and the mitochondrial F1ATPse protein.
Protein concentrations were determined by the bicinchoninic acid
(BCA) method. Protein extracts were separated by SDS-PAGE,
transferred onto a PVDF membrane (Millipore) and revealed with
a chemiluminescence kit (Millipore). For signal detection the
membranes were incubated overnight with antibodies to p21
(556431, BD-pharmigen), p53 (554294, BD-pharmingen), actin
(MAB1501R, Millipore), ß-tubulin (T0198, Sigma), Bax (A3533,
Dako), Bcl-xL (1018-1, Epitomics), Bim (AB170003, Millipore),
F1ATPase (A21350, Molecular Probe), Flag (F1804, Sigma), Mcl-
1 (sc819, Santa Cruz) PARP (AM30, Calbiochem) and Puma
(PC686, Calbiochem). HRP-conjugated secondary antibodies
were from Bio-rad.
Cellular assays
For immunocytochemichal assays, cells were grown on gelatin-
coated cover-slips, and placed under complete medium or serum-
nutrient depletion during 16 h. Cells were then fixed in 4%
paraformaldehyde for 30 min, permeabilized with 0.1% SDS for
10 min, blocked with 5% BSA in PBS for 15 min, then incubated
with the primary antibody rabbit polyclonal anti-p21 (BD
pharmigen) overnight at 4uC in 1% BSA in PBS and then with
the secondary Alexa-Fluor 568 nm antibody (Molecular probes)
for 1 h in 1% BSA in PBS at 37uC. Cells were mounted in
ProLong Gold antifade reagent with DAPI (Invitrogen) and
observed under a using a Zeiss Axiovert 200-M inverted
microscope (Carl Zeiss, Le Pecq, France). Coimmunoprecipitation
assays were performed as previously described using CHAPS
lysates [21]. Cell viability was determined by blue trypan staining
or by PI staining using flow cytometry. In these assay, analysis
were performed on cells that had reached 70–80% confluence.
‘‘BD ApoAlert APO 2.7-PE’’ (BD Biosciences) was used to
determine the percentage of apoptotic cells according to the
manufacturer’s instructions Cells were analyzed on a FACScalibur
(BD Biosciences) using Cell Quest Pro software. A minimum of
10 000 events were acquired for each condition. The debris were
excluded from the analysis according to their FSC/SSC
properties. For colony formation assays, cells were cultured in
complete medium or placed under starvation condition during
24 h. Then, 500 cells were seeded in each well of a 6-well plate for
2 weeks in complete medium, after cells were stained with 0.5%
crystal violet and 20% methanol.
Time-lapse analysis
Time-lapse video-microscopy experiments were performed
using a Leica DMI 6000B. Dishes were placed inside an Incubator
chamber to a CO2 controller that maintained the environmental
CO2 concentration at 5% for the duration of filming. Digital
pictures were acquired using MetaMorph v.7.5 software (MDS,
Foster City, CA) and saved every 10 min over 24 h using a
CollSNAP HQ2 camera. The series of photographs were
displayed as continuous time-lapse movies for analyses.
Data analysis
Data were from at least three independent experiments.
Statistical analysis of data was performed using one tail Student’s
t-test on GraphPad Prism. Error bars represent standard error of
means (SEM). The following symbols are used: *, **, *** that
correspond to a P value inferior to 0.05, 0.01 or 0.001 respectively.
Supporting Information
Figure S1 Role of p21 and p53 in cell death induced by
serum nutrient starvation. (A and B) The indicated HCT116
cells were transfected with the indicated siRNA. 48 h later, cells
were starved in EBSS medium for 24 h (EBSS) or not (CM).
Viability of the indicated cells placed under starvation during 24 h
was analyzed by PI staining and flow cytometry. Data are mean 6
SEM of three independent experiments.
(PDF)
Figure S2 Enhancement of p21 protein level in serum
withdraw medium. HCT116 wild-type cells were placed in
complete medium (CM), in serum withdrawn medium (SW) or
starved 24 h in EBSS medium (EBSS). Western blot analysis was
performed to detect p21 expression.
(PDF)
Figure S3 Enhancement ofPuma protein level in p532/2
HCT116 cells. HCT116 p532/2 cells were placed in complete
medium (CM) or starved 24 h in EBSS medium (EBSS). Western
blot analysis was performed to detect Puma expression.
(PDF)
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